Skip to main content
Premium Trial:

Request an Annual Quote

A Penny for Your Thoughts

We've got a couple of opportunities for you to share your thoughts. (Oh, come on. It's Friday. What else will you be doing?)

NIH's National Institute of General Medical Sciences is conducting an assessment of the Protein Structure Initiative and is looking for scientists and other interested parties to respond to some questions about the program. Today's the last day, so if you're an interested party, check out this website to get involved.

Elsewhere, some working groups from ABRF are getting ready to launch the second phase of their DNA variant platform study (check out GT's article on the first phase here). They're looking for people to help benchmark technologies for tracking DNA variants, including sequencing, SNP genotyping, microsatellite analysis, and more. If you're interested in participating, fill out the survey here.

 

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.